Avecho Biotechnology Statistics
Total Valuation
AVEFF has a market cap or net worth of 8.30 million. The enterprise value is 7.45 million.
| Market Cap | 8.30M |
| Enterprise Value | 7.45M |
Important Dates
The last earnings date was Monday, May 26, 2025.
| Earnings Date | May 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 3.17B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +39.74% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.90B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.83 |
| PB Ratio | 4.10 |
| P/TBV Ratio | 4.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.85 |
| EV / Sales | 10.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.33.
| Current Ratio | 2.81 |
| Quick Ratio | 2.70 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -53.64 |
Financial Efficiency
Return on equity (ROE) is -64.72% and return on invested capital (ROIC) is -35.15%.
| Return on Equity (ROE) | -64.72% |
| Return on Assets (ROA) | -31.11% |
| Return on Invested Capital (ROIC) | -35.15% |
| Return on Capital Employed (ROCE) | -93.26% |
| Revenue Per Employee | 46,730 |
| Profits Per Employee | -128,805 |
| Employee Count | 15 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 3.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.00% in the last 52 weeks. The beta is 1.13, so AVEFF's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +50.00% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 28.33 |
| Average Volume (20 Days) | 187,534 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AVEFF had revenue of 700,954 and -1.93 million in losses. Loss per share was -0.00.
| Revenue | 700,954 |
| Gross Profit | 415,822 |
| Operating Income | -1.90M |
| Pretax Income | -1.93M |
| Net Income | -1.93M |
| EBITDA | -1.81M |
| EBIT | -1.90M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.47 million in cash and 666,296 in debt, giving a net cash position of 803,185.
| Cash & Cash Equivalents | 1.47M |
| Total Debt | 666,296 |
| Net Cash | 803,185 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.02M |
| Book Value Per Share | 0.00 |
| Working Capital | 1.92M |
Cash Flow
| Operating Cash Flow | -2.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 59.32%, with operating and profit margins of -270.59% and -275.64%.
| Gross Margin | 59.32% |
| Operating Margin | -270.59% |
| Pretax Margin | -275.64% |
| Profit Margin | -275.64% |
| EBITDA Margin | -257.80% |
| EBIT Margin | -270.59% |
| FCF Margin | n/a |
Dividends & Yields
AVEFF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.74% |
| Shareholder Yield | n/a |
| Earnings Yield | -23.29% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AVEFF has an Altman Z-Score of -73.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -73.09 |
| Piotroski F-Score | 2 |